U.S. markets closed

uniQure N.V. (QURE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.98-0.32 (-1.85%)
At close: 04:00PM EDT
17.15 +0.17 (+1.00%)
After hours: 04:44PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close17.30
Bid16.25 x 800
Ask17.79 x 800
Day's Range16.97 - 17.90
52 Week Range12.52 - 36.55
Avg. Volume693,885
Market Cap793.46M
Beta (5Y Monthly)1.07
PE Ratio (TTM)2.23
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
31% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for QURE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • uniQure N.V.
    QURE: Lowering target price to $21.00UNIQURE NV has an Investment Rating of BUY; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • Simply Wall St.

    These Analysts Just Made A Neat Downgrade To Their uniQure N.V. (NASDAQ:QURE) EPS Forecasts

    The latest analyst coverage could presage a bad day for uniQure N.V. ( NASDAQ:QURE ), with the analysts making...

  • Motley Fool

    Why uniQure Stock Is Crashing Today

    Shares of uniQure N.V. (NASDAQ: QURE) are crashing today, down by 32.6% as of 11:19 a.m. ET. The steep decline came after the gene therapy specialist provided its second-quarter update Monday morning. Investors weren't all that interested in uniQure's financial results.

  • Benzinga

    Why UniQure Shares Are Plummeting Today?

    Tucked in its Q2 earnings release, UniQure N.V. (NASDAQ: QURE) said that in July, it had observed suspected, unexpected severe adverse reactions (SUSARs) in two patients after they were treated with the "higher dose" of AMT-130 in a European Phase 1b/2 trial. AMT-130 is a gene therapy candidate for Huntington's disease. A third patient treated back in March in the U.S., had their side effect deemed unrelated to the candidate, but it was then reclassified as a severe adverse reaction after review